What did Haemonetics Corporation pay for Attune Medical?

Haemonetics Corporation acquired Attune Medical for $160.0M in 2024 (28.6x EBITDA), equivalent to 7.30x revenue. Target revenue was approximately $22.0M. Target EBITDA was approximately $5.6M.

What does Attune Medical do?

Attune Medical is a medical devices business.

What multiple did Haemonetics Corporation pay for Attune Medical?

28.6x EBITDA and 7.30x revenue, based on disclosed deal value of $160.0M and disclosed financials.

M&A TRANSACTION · 2024

Attune Medical acquired by Haemonetics Corporation

$160.0M· 28.6x EBITDA· 7.30x revenue

Target

Attune Medical

Acquirer

Haemonetics Corporation

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$22.0M

EBITDA

$5.6M

Deal Value

$160.0M

EV/EBITDA

28.6x

Context

This $160.0M acquisition of Attune Medical by Haemonetics Corporation sits in the medical devices sub-vertical. The 28.6x EBITDA multiple paid in 2024 can be compared against the population median for medical devices transactions of similar size on our Medical Devices valuation hub. Haemonetics Corporation is acquiring as a strategic buyer; see how strategic acquirers typically price medical devices businesses on our Medical Devices strategic buyer-pool page.

Source

Data sourced from Press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own medical devices

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the Attune Medical acquisition.

Citation: ExitValue.ai. (2024). Attune Medical acquired by Haemonetics Corporation. https://exitvalue.ai/deals/attune-medical-acquired-by-haemonetics-corporation-hc-2024-0033